Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pierre Lauroua"'
Autor:
Maryse Puntous, S. Pujol, Marie Miremont, I. Roger, Pierre Lauroua, F. Xuereb, Stéphane Bouchet
Publikováno v:
Transfusion Clinique et Biologique. 24:300
La circulaire du 15/12/2003 relative a la realisation de l’acte transfusionnel recommande de reserver une voie veineuse a la transfusion des produits sanguins labiles. Une enquete multicentrique de pratiques sur la transfusion et la perfusion simul
Autor:
Rodolphe Thiébaut, Aude Kostrzewa, Guy Leverger, G. Coureau, Véronique Gilleron, Marthe-Aline Jutand, Cyrielle Beaubois, Julien Jeanpetit, Michel Jeanne, Helder Fernandes, Thierry Leblanc, Pierre Lauroua, Y Perel, Nathalie Aladjidi
Publikováno v:
Pediatric Blood & Cancer. 64:e26683
Background Childhood autoimmune hemolytic anemia (AIHA) is a rare and severe disease characterized by hemolysis and positive direct antiglobulin test (DAT). Few epidemiologic indicators are available for the pediatric population. The objective of our
Publikováno v:
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 56:1627-1635
In order to remedy the limitations of state-of-the-art methods for red blood cells grouping and antibody screening we have tried to develop a new type of immunosensors based upon a metallic substrate. The first two steps of the manufacturing of such
Autor:
France Noizat-Pirenne, Pierre-Yves Le Pennec, Isabelle Mouro, Anne-Marie Rouzaud, Genevieve Juszczak, Michele Roussel, Pierre Lauroua, Claire Krause, Philippe Rouger, Jean-Pierre Cartron, Helene Ansart-Pirenne
Publikováno v:
Transfusion. 42(5)
BACKGROUND: D(C)(e) and D(C)e haplotypes may be encountered in the white population. Few data are available on the molecular backgrounds responsible for depressed expression of C and e. STUDY DESIGN AND METHODS: Individuals of white origin carrying a
Publikováno v:
Transfusion Clinique et Biologique. 21:268
Le CHU de Bordeaux consomme environ 55 000 PSL par an dont environ la moitie pour l’Hopital Haut-Leveque (HL), l’autre moitie pour l’Hopital Pellegrin ou se trouve le site principal EFS-AQLI. Ces deux sites sont distants d’une ½ heure. Pour
Autor:
Mathilde Beguet, T. Pistone, Denis Malvy, Loic Raffray, Marie-Catherine Receveur, Pierre Lauroua
Publikováno v:
Malaria Journal
Malaria Journal, BioMed Central, 2014, 13, pp.398. ⟨10.1016/S0035-9203(03)90079-4⟩
Malaria Journal, BioMed Central, 2014, 13, pp.398. ⟨10.1016/S0035-9203(03)90079-4⟩
Background Parenteral artesunate is recommended as first-line therapy for severe and complicated malaria. Although its efficacy has been proven, long-term safety profile is still under evaluation. Several cases of delayed haemolytic anaemia occurred